- Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia2016 | First Faculty of Medicine
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy2015 | First Faculty of Medicine
- Current treatment options for patients with dyslipidemia and cardiometabolic syndrome2015 | Faculty of Medicine in Pilsen
- Consequences of metabolic syndrome in cardiology2004 | First Faculty of Medicine
- ACCORD-Lipid trial, postprandial lipaemia and cardiovascular risk: outcomes a current interpretation2015 | Faculty of Medicine in Hradec Králové